Author:
ŞAHİN Derya,BAŞÇI Semih,TEMİZEL Ayşe,BATGİ Hikmetullah,UNCU ULU Bahar,BAYSAL Nuran Ahu,İSKENDER Dicle,KIZIL ÇAKIR Merih,DAL Sinan,ALTUNTAŞ Fevzi
Publisher
Journal of Health Sciences and Medicine
Reference17 articles.
1. 1. Mohty M. Indications for HSCT in adults: acute myeloid leukaemia. In: Appertley J, Carreras E, Gluckan E, Masszi T, editors. The EBMT handbook – haematopoietic stem cell transplantation. 6. ed. Paris: ESH – European School of Haematology; 2012: 317-29.
2. 2. Fey MF, Buske C. ESMO Guidelines Working Group. Acute myeloblastic leukaemias in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24: 38-43.
3. 3. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J 2016; 6: e441.
4. 4. Merdin A, Dal MS, Çakar MK, et al. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin and MPV levels in acute myeloid leukemia patients with WT1, FLT3 or NPM gene mutations . Medicine 2020; 99: 14(e19627).
5. 5. Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49: 137–49.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献